The chip contains 1500 pixels replacing the light-receiving cells that have died in retinitis pigmentosa patients by receiving external light and then transmitting those signals directly to the brain.
In their study, the researchers used mammalian retinas with a degeneration of photoreceptors in order to have an experimental model of different degenerative pathologies of the retina, such as Retinitis Pigmentosa or macular degeneration.
Those in the US suffering from blindness due to retinis pigmentosa (RP) will now be able to regain some vision bionically for the first time ever, thanks to Second Sight's Argus II retinal prosthesis.
Argus II is intended to provide electrical stimulation of the retina to induce visual perception in blind individuals with retinitis pigmentosa and has the capacity to offer life-changing visual capabilities to those currently unable to see anything except, at best, extremely bright lights.